{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:07:08Z","timestamp":1791094028125,"version":"4.1.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,2,15]]},"abstract":"<jats:p>Multiple myeloma (MM) is associated with severe normochromic\/normocytic anemia. This study demonstrates that the abnormal up-regulation of apoptogenic receptors, including both Fas ligand (L) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), by highly malignant myeloma cells is involved in the pathogenesis of the ineffective erythropoiesis and chronic exhaustion of the erythroid matrix. By measuring Fas-L and TRAIL in plasma cells and the content of glycophorin A (GpA) in erythroblasts from a cohort of 28 untreated, newly diagnosed patients with MM and 7 with monoclonal gammopathy of undetermined significance (MGUS), selected in relation to their peripheral hemoglobin values, results showed that both receptors occurred at high levels in 15 severely anemic MM patients. Their marrow erythropoietic component was low and included predominantly immature GpA+dim erythroblasts, in contrast with the higher relative numbers of mature GpA+bright erythroid cells observed in the nonanemic patients and those with MGUS. In cocultures with autologous Fas-L+\/TRAIL+ myeloma cells, the expanded GpA+dim erythroid population underwent prompt apoptosis after direct exposure to malignant plasma cells, whereas erythroblasts from nonanemic patients were scarcely affected. The evidence that Fas-L+\/TRAIL+malignant plasma cells prime erythroblast apoptosis by direct cytotoxicity was also supported by the increase of FLICE in fresh immature GpA+dim erythroid cells, whereas ICE and caspase-10 increased in subsequent maturative forms. In addition, GATA-1, a survival factor for erythroid precursors, was remarkably down-regulated in fresh erythroblasts from the severely anemic patients. These results indicate that progressive destruction of the erythroid matrix in aggressive MM is due to cytotoxic mechanisms based on the up-regulation in myeloma cells of Fas-L, TRAIL, or both. It is conceivable that the altered regulation of these receptors defines a peculiar cytotoxic phenotype that drives the progression of aggressive MM.<\/jats:p>","DOI":"10.1182\/blood.v99.4.1305","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:40Z","timestamp":1027774000000},"page":"1305-1313","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":89,"title":["Negative regulation of erythroblast maturation by Fas-L+\/TRAIL+ highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma"],"prefix":"10.1182","volume":"99","author":[{"given":"Franco","family":"Silvestris","sequence":"first","affiliation":[{"name":"From DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cafforio","sequence":"additional","affiliation":[{"name":"From DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tucci","sequence":"additional","affiliation":[{"name":"From DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Dammacco","sequence":"additional","affiliation":[{"name":"From DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021300114647100_B1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM199706053362307","article-title":"Multiple myeloma.","volume":"336","author":"Bataille","year":"1997","journal-title":"N Engl J Med."},{"key":"2020021300114647100_B2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma.","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer."},{"key":"2020021300114647100_B3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2141.1992.tb06939.x","article-title":"Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production.","volume":"82","author":"Beguin","year":"1992","journal-title":"Br J Haematol."},{"key":"2020021300114647100_B4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00062752-199603030-00005","article-title":"Cytokine regulation of apoptosis in hematopoietic precursor cells.","volume":"3","author":"Park","year":"1996","journal-title":"Curr Opin Hematol."},{"key":"2020021300114647100_B5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood.V91.4.1235","article-title":"Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon-\u03b3 to produce erythroid cell apoptosis.","volume":"91","author":"Dai","year":"1998","journal-title":"Blood."},{"key":"2020021300114647100_B6","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","article-title":"Progress in understanding the pathogenesis of the anemia of chronic disease.","volume":"80","author":"Means","year":"1992","journal-title":"Blood."},{"key":"2020021300114647100_B7","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1002\/1097-0142(19871215)60:12<2965::AID-CNCR2820601219>3.0.CO;2-O","article-title":"The effect of tumor necrosis factor on normal human hematopoietic progenitors.","volume":"60","author":"Abboud","year":"1987","journal-title":"Cancer."},{"key":"2020021300114647100_B8","first-page":"65","article-title":"Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.","volume":"10","author":"Jourdan","year":"1999","journal-title":"Eur Cytokine Netw."},{"key":"2020021300114647100_B9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood.V97.5.1155","article-title":"Fas-L upregulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression.","volume":"97","author":"Silvestris","year":"2001","journal-title":"Blood."},{"key":"2020021300114647100_B10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V93.3.796","article-title":"Apoptotic role of Fas\/Fas ligand system in the regulation of erythropoiesis.","volume":"93","author":"De Maria","year":"1999","journal-title":"Blood."},{"key":"2020021300114647100_B11","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","article-title":"Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.","volume":"85","author":"Maciejewski","year":"1995","journal-title":"Blood."},{"key":"2020021300114647100_B12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/10428199609045713","article-title":"Fas antigen (CD95) and hematopoietic progenitor cells.","volume":"24","author":"Nagafuji","year":"1996","journal-title":"Leuk Lymphoma."},{"key":"2020021300114647100_B13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(95)90071-3","article-title":"FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.","volume":"81","author":"Chinnaiyan","year":"1995","journal-title":"Cell."},{"key":"2020021300114647100_B14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0955-0674(99)80034-9","article-title":"Apoptosis control by death and decoy receptors.","volume":"11","author":"Ashkenazi","year":"1999","journal-title":"Curr Opin Cell Biol."},{"key":"2020021300114647100_B15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis.","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity."},{"key":"2020021300114647100_B16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T","article-title":"Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage.","volume":"28","author":"Mariani","year":"1996","journal-title":"Eur J Immunol."},{"key":"2020021300114647100_B17","first-page":"3616","article-title":"TNF- related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis.","volume":"95","author":"Zamai","year":"2000","journal-title":"Blood."},{"key":"2020021300114647100_B18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2249.1998.00711.x","article-title":"Fas\/Fas ligand (Fas-L)-deregulated apoptosis and IL-6 insensibility in highly malignant myeloma cells.","volume":"114","author":"Frassanito","year":"1998","journal-title":"Clin Exp Immunol."},{"key":"2020021300114647100_B19","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0301-472X(99)00105-8","article-title":"Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma.","volume":"27","author":"Fossa","year":"1999","journal-title":"Exp Hematol."},{"key":"2020021300114647100_B20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/10428199509059639","article-title":"Erythropoiesis and erythropoietin in multiple myeloma.","volume":"18","author":"Beguin","year":"1995","journal-title":"Leuk Lymphoma."},{"key":"2020021300114647100_B21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1182\/blood.V69.1.255.255","article-title":"Flow cytometry analysis of human bone marrow, I: normal erythroid development.","volume":"69","author":"Loken","year":"1987","journal-title":"Blood."},{"key":"2020021300114647100_B22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/cimm.2000.1650","article-title":"Regulation of TRAIL-induced apoptosis by transcription factors.","volume":"201","author":"Go\u0308ke","year":"2000","journal-title":"Cell Immunol."},{"key":"2020021300114647100_B23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1182\/blood.V80.3.575.575","article-title":"GATA-binding transcription factors in hematopoietic cells.","volume":"80","author":"Orkin","year":"1992","journal-title":"Blood."},{"key":"2020021300114647100_B24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/46809","article-title":"Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1.","volume":"401","author":"De Maria","year":"1999","journal-title":"Nature."},{"key":"2020021300114647100_B25","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V91.8.2679.2679_2679_2688","article-title":"Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation.","volume":"91","author":"Dhodapkar","year":"1998","journal-title":"Blood."},{"key":"2020021300114647100_B26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V95.2.388","article-title":"Serum syndecan-1: a new independent prognostic marker in multiple myeloma.","volume":"95","author":"Seidel","year":"2000","journal-title":"Blood."},{"key":"2020021300114647100_B27","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1084\/jem.182.5.1597","article-title":"Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic lymphocytes.","volume":"182","author":"Verhofen","year":"1995","journal-title":"J Exp Med."},{"key":"2020021300114647100_B28","doi-asserted-by":"crossref","first-page":"20049","DOI":"10.1074\/jbc.274.29.20049","article-title":"Suicidal tendencies: apoptotic cell death by caspase family proteinases.","volume":"274","author":"Wolf","year":"1999","journal-title":"J Biol Chem."},{"key":"2020021300114647100_B29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood.V74.1.130.130","article-title":"Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice.","volume":"74","author":"Johnson","year":"1989","journal-title":"Blood."},{"key":"2020021300114647100_B30","first-page":"2986","article-title":"Phase I study of recombinant tumor necrosis factor in cancer patients.","volume":"47","author":"Blick","year":"1987","journal-title":"Cancer Res."},{"key":"2020021300114647100_B31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/10428199609045719","article-title":"Cytokine expression in multiple myeloma and monoclonal gammopathy: analysis by reverse transcription\/polymerase chain reaction and quantitative PCR.","volume":"24","author":"Soutar","year":"1996","journal-title":"Leuk Lymphoma."},{"key":"2020021300114647100_B32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(87)91850-2","article-title":"Evidence for tumour necrosis factor\/cachectin production in cancer.","volume":"2","author":"Balkwill","year":"1987","journal-title":"Lancet."},{"key":"2020021300114647100_B33","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.4049\/jimmunol.137.11.3544","article-title":"Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells.","volume":"137","author":"Takahashi","year":"1986","journal-title":"J Immunol."},{"key":"2020021300114647100_B34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1200\/JCO.1986.4.2.137","article-title":"Phase I trial of recombinant interferon gamma in cancer patients.","volume":"4","author":"Vadhan-Raj","year":"1986","journal-title":"J Clin Oncol."},{"key":"2020021300114647100_B35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.1310","article-title":"IFN-gamma induces cell death in human hepatoma cells through a TRAIL\/death receptor-mediated apoptotic pathway.","volume":"15","author":"Shin","year":"2001","journal-title":"Int J Cancer."},{"key":"2020021300114647100_B36","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1182\/blood.V93.10.3309.410k04_3309_3316","article-title":"Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells.","volume":"93","author":"Dai","year":"1999","journal-title":"Blood."},{"key":"2020021300114647100_B37","first-page":"817","article-title":"Tumor necrosis factor-\u03b1 and interferon-\u03b3 in serum of multiple myeloma patients.","volume":"10","author":"Pisa","year":"1990","journal-title":"Anticancer Res."},{"key":"2020021300114647100_B38","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.leu.2401501","article-title":"TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells.","volume":"13","author":"Gazitt","year":"1999","journal-title":"Leukemia."},{"key":"2020021300114647100_B39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-5793(00)02042-1","article-title":"Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types.","volume":"482","author":"Zhang","year":"2000","journal-title":"FEBS Lett."},{"key":"2020021300114647100_B40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1083\/jcb.137.1.221","article-title":"Interleukin 1\u03b2-converting enzyme related proteases\/caspases are involved in TRAIL- induced apoptosis of myeloma and leukemia cells.","volume":"137","author":"Mariani","year":"1997","journal-title":"J Cell Biol."},{"key":"2020021300114647100_B41","first-page":"4122","article-title":"Thyroid carcinoma cells are resistant to Fas-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.","volume":"60","author":"Mitsiades","year":"2000","journal-title":"Cancer Res."},{"key":"2020021300114647100_B42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1101\/gad.8.10.1184","article-title":"Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells.","volume":"8","author":"Weiss","year":"1994","journal-title":"Genes Dev."},{"key":"2020021300114647100_B43","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1073\/pnas.92.21.9623","article-title":"Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis.","volume":"92","author":"Weiss","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021300114647100_B44","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.bmt.1702348","article-title":"Autologous and allogeneic stem cell transplantation in multiple myeloma.","volume":"25(suppl 2)","author":"Goldschmidt","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"2020021300114647100_B45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)65265-0","article-title":"CD95 ligand (CD95L) in normal human lymphoid tissues. A subset of plasma cells are prominent producers of CD95L.","volume":"154","author":"Stra\u0308ter","year":"1999","journal-title":"Am J Pathol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/4\/1305\/1680436\/h8040201305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/4\/1305\/1680436\/h8040201305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T06:42:11Z","timestamp":1704523331000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/4\/1305\/109992\/Negative-regulation-of-erythroblast-maturation-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,15]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.4.1305","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2,15]]}}}